Kalé Kponee-Shovein
Boston
Education
Sc.D., epidemiology and environmental health, and Sc.M., biostatistics, Harvard University; M.P.H., epidemiology, Boston University; B.A., psychology and Spanish, Saint Louis University
Summary of Experience
Dr. Kponee-Shovein is an epidemiologist with analytical experience in causal inference methods, outcomes research, drug safety, health economics, and health care litigation. She has a wide range of experience with various types of health care data, including insurance claims, electronic medical records, chart review, clinical trials, and survey data. She has also provided regulatory and strategic consulting on drug registration and real-world evidence generation for US Food and Drug Administration new drug application (NDA), supplemental new drug application (sNDA), and orphan drug designation (ODD) submissions. Dr. Kponee-Shovein has developed and led research projects in resource-poor settings. She has also presented abstracts at conferences on epidemiology and environmental health sciences, and coauthored articles in peer-reviewed journals such as JAMA Internal Medicine and the American Journal of Epidemiology. Dr. Kponee-Shovein is an adjunct lecturer in the epidemiology department at the Harvard T.H. Chan School of Public Health.
Selected Publishing
-
Epidemiology and Patient Journey of Rett Syndrome in the United States: A Real-World Evidence Study
BMC Neurology, 2023
2023May D, Kponee-Shovein K, Mahendran M, Downes N, Sheng K, Lefebvre P, Cheng WY
-
Impact of choice of inhalers for asthma care on global carbon footprint and societal costs: a long-term economic evaluation
Journal of Medical Economics, 2022
2022Kponee-Shovein K, Marvel J, Ishikawa R, Choubey A, Kaur H, Ngom K, Fakih I, Swartz N, Schatzki T, Signorovitch J
-
Estimating the US pericarditis prevalence using National Health Encounter Surveillance Databases
Current Medical Research and Opinion, 2022
2022Luis SA, LeWinter MM, Magestro M, DerSarkissian M, Duh MS, Chang R, Kponee-Shovein K, Muthukumar A, Hu X, Lim-Watson MZ, Klein AL
-
Carbon footprint and associated costs of asthma exacerbation care among UK adults
Journal of Medical Economics, 2022
2022Kponee-Shovein K, Marvel J, Ishikawa R, Choubey A, Kaur H, Thokala P, Ngom K, Fakih I, Schatzki T, Signorovitch J
-
Profiling Disease and Economic Burden in CRSwNP Using Machine Learning
Journal of Asthma and Allergy, 2022
2022Bhattacharyya N, Silver J, Bogart M, Kponee-Shovein K, Cheng WY, Cheng M, Cheung HC, Duh MS, Hahn B
-
Suicidal ideation and attempts in the United States of America among stimulant-treated, non-stimulant-treated, and untreated patients with a diagnosis of attention-deficit/hyperactivity disorder
Journal of Affective Disorders, April 2020
2020Siffel C, DerSarkissian M, Kponee-Shovein K, Spalding W, Gu Y, Cheng M, Duh M
